Cite
MLA Citation
Sjoerd T T Schetters et al.. “Monocyte-derived APCs are central to the response of PD1 checkpoint blockade and provide a therapeutic target for combination therapy.” Journal for immunotherapy of cancer, vol. 8, no. 2, 2020, p. . http://access.bl.uk/ark:/81055/vdc_100127565002.0x000030